SCHEMBL7485346

SCHEMBL7485346

O=C(C=Cc1ccccc1Cl)Nc1nnc(NCCN2CCCC2)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.53
CYP2C19 P33261 2/20 0.53
MAPT P10636 9/20 0.46
HPGD P15428 1/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 2/20 0.46
RAB9A P51151 8/20 0.46
NPC1 O15118 6/20 0.46
MAOB P27338 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
POLB P06746 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7484285 1.00 CYP3A4 (0.53) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7485286 0.87 MAPT (0.51) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7485298 0.87 MAPT (0.51) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7480451 0.85 HSP90AA1 (0.49) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL7480459 0.85 HSP90AA1 (0.49) MAPTHPGDMEN1KMT2ASMN1; SMN2
SCHEMBL7483528 0.82 ITGB2 (0.51) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7483535 0.82 ITGB2 (0.51) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7492399 0.82 MAPT (0.60) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7488964 0.82 RAB9A (0.53) CYP3A4CYP2C19MAPTHPGDMEN1
SCHEMBL7482925 0.82 MAPT (0.60) CYP3A4CYP2C19MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP claimed
US-6150385-A VIRICIDE WITH ACTIVITY AGAINST CYTOMEGALO VIRUS (CMV), HERPES VIRUS INCLUDING VARICELLA ZOSTER VIRUS, THE EPSTEIN-BARR VIRUS, THE HERPES SIMPLEX VIRUS, AND THE HUMAN HERPES VIRUS TYPE 8 (HHV-8) PHARMACIA & UPJOHN COMPANY (US) 2000-11-21 US claimed
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP disclosed